KG
King Pharmaceuticals
KG • XNYS
King Pharmaceuticals is a publicly traded company trading on XNYS, led by CEO Bradford Luke Ledbetter, with a market cap of $93.3M.
Market Cap$93.3M
CEOBradford Luke Ledbetter
CountryUnited States of America
Next EarningsMay 15, 2026 · in a monthQ1 2026
Financials
KG
King Pharmaceuticals FAQ
Common questions about King Pharmaceuticals
King Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 15, 2026.